Waller, C. F., Ranganna, G. M., Pennella, E. J., Blakeley, C., Bronchud, M. H., Mattano Jr, L. A., . . . Barve, A. (2019). Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia. Ann Hematol.
Chicago Style CitationWaller, Cornelius F., et al. "Randomized Phase 3 Efficacy and Safety Trial of Proposed Pegfilgrastim Biosimilar MYL-1401H in the Prophylactic Treatment of Chemotherapy-induced Neutropenia." Ann Hematol 2019.
Cita MLAWaller, Cornelius F., et al. "Randomized Phase 3 Efficacy and Safety Trial of Proposed Pegfilgrastim Biosimilar MYL-1401H in the Prophylactic Treatment of Chemotherapy-induced Neutropenia." Ann Hematol 2019.
Atenció: Aquestes cites poden no estar 100% correctes.